Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Current Opinion in Allergy and Clinical Immunology|December 7, 2020
Alpha1-antitrypsin deficiency and asthmaLaura Pini, Giovanni Paoletti, Enrico Heffler, et al.
Current Opinion in Allergy and Clinical Immunology|December 28, 2020
Allergen immunotherapy and biologics in respiratory allergy: friends or foes?Giacomo Malipiero, Giulio Melone, Francesca Puggioni, et al.
Current Opinion in Allergy and Clinical Immunology|November 23, 2016
Rhinitis: adherence to treatment and new technologiesFulvio Braido, Ilaria Baiardini, Francesca Puggioni, et al.
Frontiers in Medicine|September 16, 2017
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic AsthmaDiego Bagnasco, Matteo Ferrando, Gilda Varricchi, et al.
Therapeutic Advances in Respiratory Disease|November 19, 2016
Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experienceGilda Varricchi, Diego Bagnasco, Matteo Ferrando, et al.
Current Allergy and Asthma Reports|February 17, 2019
Microarray Immunodiagnostics for AeroallergensEnrico Heffler, Francesca Puggioni, Desideria Descalzi, et al.
The World Allergy Organization Journal|May 11, 2018
Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosisEnrico Heffler, Francesca Puggioni, Silvia Peveri, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 8, 2018
Current insights in allergen immunotherapyGiovanni Passalacqua, Diego Bagnasco, Matteo Ferrando, et al.
Current Opinion in Allergy and Clinical Immunology|June 26, 2023
COPD and biologic treatment: state of the artSebastian Ferri, Giovanni Paoletti, Corrado Pelaia, et al.
Current Pharmaceutical Biotechnology|April 18, 2017
New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic DiseasesMatteo Ferrando, Diego Bagnasco, Giovanni Passa-Lacqua, et al.
Pageof 8